New inhaled drug put to the test in healthy volunteers
Knowledge-focused
Not yet recruiting
This early-stage study tests whether an experimental inhaled powder called SYH2059 is safe and how the body processes it. About 84 healthy adults aged 18 to 55 will receive either the drug or a placebo. The goal is to check for side effects and measure drug levels in the blood, n…
Phase: PHASE1 • Sponsor: InnovStone Therapeutics Limited • Aim: Knowledge-focused
Last updated Apr 29, 2026 01:52 UTC